Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Counting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis

1. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Шарҳ мақолаTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 иқтибос

   ABIABI:AkademIndex/openalex/2017.review-article.000004

2. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

   МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 иқтибос

   ABIABI:AkademIndex/openalex/2018.article.000181

3. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

   M. Bonnet, Mathieu Bastard, Philipp du Cros +9

   МақолаTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20150 иқтибос

   ABIABI:AkademIndex/openalex/2015.article.000040